{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,19]],"date-time":"2026-09-19T21:36:54Z","timestamp":1789853814023,"version":"4.0.1"},"reference-count":48,"publisher":"Elsevier BV","issue":"6","license":[{"start":{"date-parts":[[2009,3,1]],"date-time":"2009-03-01T00:00:00Z","timestamp":1235865600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Journal of Psychiatric Research"],"published-print":{"date-parts":[[2009,3]]},"DOI":"10.1016\/j.jpsychires.2008.09.001","type":"journal-article","created":{"date-parts":[[2008,10,19]],"date-time":"2008-10-19T08:08:01Z","timestamp":1224403681000},"page":"642-648","source":"Crossref","is-referenced-by-count":16,"title":["The selective serotonin re-uptake inhibitor escitalopram modulates the panic response to cholecystokinin tetrapeptide in healthy men depending on 5-HTTLPR genotype"],"prefix":"10.1016","volume":"43","author":[{"given":"Michael","family":"Kellner","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christoph","family":"Muhtz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"C\u00fcneyt","family":"Demiralay","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jana","family":"Husemann","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wiebke","family":"Koelsch","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alexander","family":"Yassouridis","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Klaus","family":"Wiedemann","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.jpsychires.2008.09.001_bib1","doi-asserted-by":"crossref","first-page":"74","DOI":"10.1007\/s002130050112","article-title":"The effect of chronic fluvoxamine on hormonal and psychological responses to buspirone in normal volunteers","volume":"128","author":"Anderson","year":"1996","journal-title":"Psychopharmacology"},{"key":"10.1016\/j.jpsychires.2008.09.001_bib2","first-page":"97","article-title":"Pharmacologic effect of imipramine, paroxetine, and sertraline on 35% carbon dioxide hypersensitivity in panic patients: a double-blind, random, placebo-controlled study","volume":"17","author":"Bertani","year":"1997","journal-title":"Journal of Clinical Pharmacology"},{"key":"10.1016\/j.jpsychires.2008.09.001_bib3","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1186\/1744-9081-3-41","article-title":"Lack of association between the serotonin transporter promoter polymorphism (5-HTTLPR) and panic disorder: a systematic review and meta-analysis","volume":"3","author":"Blaya","year":"2001","journal-title":"Behavioral and Brain Functions"},{"key":"10.1016\/j.jpsychires.2008.09.001_bib4","doi-asserted-by":"crossref","first-page":"635","DOI":"10.1111\/j.1476-5381.1991.tb12225.x","article-title":"Pharmacology of a cholecystokinin receptor on 5-hydroxytryptamine neurons in dorsal raphe of the rat","volume":"102","author":"Boden","year":"1991","journal-title":"British Journal of Pharmacology"},{"key":"10.1016\/j.jpsychires.2008.09.001_bib5","doi-asserted-by":"crossref","first-page":"261","DOI":"10.1176\/ajp.151.2.261","article-title":"Imipramine antagonism of the panicogenic effects of cholecystokinin tetrapeptide in panic disorder patients","volume":"151","author":"Bradwejn","year":"1994","journal-title":"American Journal of Psychiatry"},{"key":"10.1016\/j.jpsychires.2008.09.001_bib6","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1080\/713783681","article-title":"Cholecystokinin and panic disorder: past and future clinical research strategies","volume":"234","author":"Bradwejn","year":"2001","journal-title":"Scandinavian Journal of Clinical and Laboratory Investigation"},{"key":"10.1016\/j.jpsychires.2008.09.001_bib7","doi-asserted-by":"crossref","first-page":"44","DOI":"10.3758\/CABN.6.1.44","article-title":"Neuroimaging studies of serotonin gene polymorphisms: exploring the interplay of genes, brain, and behaviour","volume":"6","author":"Brown","year":"2006","journal-title":"Cognitive, Affective, and Behavioral Neuroscience"},{"key":"10.1016\/j.jpsychires.2008.09.001_bib8","doi-asserted-by":"crossref","first-page":"1477","DOI":"10.1517\/13543784.11.10.1477","article-title":"Escitalopram","volume":"11","author":"Burke","year":"2002","journal-title":"Expert Opinion on Investigational Drugs"},{"key":"10.1016\/j.jpsychires.2008.09.001_bib9","first-page":"189","article-title":"Serotonin related functions in panic-anxiety: a critical overview","volume":"6","author":"Coplan","year":"1992","journal-title":"Neuropsychopharmacology"},{"key":"10.1016\/j.jpsychires.2008.09.001_bib10","doi-asserted-by":"crossref","first-page":"345","DOI":"10.1177\/026988119701100410","article-title":"Changes in plasma prolactin during SSRI treatment: evidence for a delayed increase in 5-HT neurotransmission","volume":"11","author":"Cowen","year":"1997","journal-title":"Journal of Psychopharmacology"},{"key":"10.1016\/j.jpsychires.2008.09.001_bib11","doi-asserted-by":"crossref","first-page":"2586","DOI":"10.1523\/JNEUROSCI.3769-04.2005","article-title":"A functional genetic variation of the serotonin (5-HT) transporter affects 5-HT1A receptor binding in humans","volume":"25","author":"David","year":"2005","journal-title":"Journal of Neuroscience"},{"key":"10.1016\/j.jpsychires.2008.09.001_bib12","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1016\/S0893-133X(98)00074-8","article-title":"Acute and chronic role of 5-HT3 neuronal system on behavioural and neuroendocrine changes induced by intravenous choleystokinin tetrapeptide administration in humans","volume":"20","author":"D\u00e9p\u00f4t","year":"1999","journal-title":"Neurospychopharmacology"},{"key":"10.1016\/j.jpsychires.2008.09.001_bib13","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1016\/0165-1781(87)90002-3","article-title":"The measurement of lactate-induced panic anxiety","volume":"20","author":"Dillon","year":"1987","journal-title":"Psychiatry Research"},{"key":"10.1016\/j.jpsychires.2008.09.001_bib14","first-page":"669","article-title":"Evaluation of the CCK-4 model as a challenge paradigm in a population of healthy volunteers within a proof-of-concept study","volume":"32","author":"Eser","year":"2007","journal-title":"Psychopharmacology"},{"key":"10.1016\/j.jpsychires.2008.09.001_bib15","series-title":"Structured clinical interview for DSM-IV axis II personality disorders (SKID-II)","author":"First","year":"1997"},{"key":"10.1016\/j.jpsychires.2008.09.001_bib16","doi-asserted-by":"crossref","first-page":"391","DOI":"10.1016\/j.jchromb.2006.10.058","article-title":"Determination of citalopram and escitalopram together with their active metabolites desmethyl(es)-citalopram in human serum by column-switching high performance liquid chromatography (HPLC) with spectrometric detection","volume":"848","author":"Greiner","year":"2007","journal-title":"Journal of Chromatography B"},{"key":"10.1016\/j.jpsychires.2008.09.001_bib17","doi-asserted-by":"crossref","first-page":"235","DOI":"10.1177\/026988110201600308","article-title":"Enhancement of stress-induced pituitary hormone release and cardiovascular activation by antidepressant treatment in healthy men","volume":"16","author":"Je\u017eov\u00e1","year":"2002","journal-title":"Journal of Psychopharmacology"},{"key":"10.1016\/j.jpsychires.2008.09.001_bib18","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/S0022-3956(01)00042-5","article-title":"Intravenous C-type natriuretic peptide augments behavioral and endocrine effects of cholecystokinin tetrapeptide in healthy man","volume":"36","author":"Kellner","year":"2002","journal-title":"Journal of Psychiatric Research"},{"key":"10.1016\/j.jpsychires.2008.09.001_bib19","doi-asserted-by":"crossref","first-page":"310","DOI":"10.1007\/s00213-004-2025-1","article-title":"Effects of a metabotropic glutamate (2\/3) receptor agonist (LY544344\/LY354740) on panic anxiety induced by cholecystokinin tetrapeptide in healthy humans: preliminary results","volume":"179","author":"Kellner","year":"2005","journal-title":"Psychopharmacology"},{"key":"10.1016\/j.jpsychires.2008.09.001_bib20","doi-asserted-by":"crossref","first-page":"648","DOI":"10.1016\/0006-3223(95)00479-3","article-title":"Effect of acute tryptophan depletion on behavioural, cardiovascular, and hormonal sensitivity to cholecystokinin-tetrapeptide challenge in healthy volunteers","volume":"40","author":"Koszycki","year":"1996","journal-title":"Biological Psychiatry"},{"key":"10.1016\/j.jpsychires.2008.09.001_bib21","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1002\/(SICI)1520-6394(1998)8:1<1::AID-DA1>3.0.CO;2-G","article-title":"Behavioral, cardiovascular, and neuroendocrine profiles following CCK-4 challenge in healthy volunteers: a comparison of panickers and nonpanickers","volume":"8","author":"Koszycki","year":"1998","journal-title":"Depression and Anxiety"},{"key":"10.1016\/j.jpsychires.2008.09.001_bib22","doi-asserted-by":"crossref","first-page":"364","DOI":"10.1016\/S0006-3223(97)00536-2","article-title":"The role of the beta-noradrenergic system in cholecystokinin-tetrapeptide-induced panic symptoms","volume":"44","author":"Le M\u00e9lledo","year":"1998","journal-title":"Biological Psychiatry"},{"key":"10.1016\/j.jpsychires.2008.09.001_bib23","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1016\/S0893-133X(98)00057-8","article-title":"Sensitivity to CCK-4 in women with and without premenstrual dysphoric disorder (PMDD) during their follicular and luteal phases","volume":"20","author":"Le Mell\u00e9do","year":"1999","journal-title":"Neuropsychopharmacology"},{"key":"10.1016\/j.jpsychires.2008.09.001_bib24","doi-asserted-by":"crossref","first-page":"628","DOI":"10.1016\/S0893-133X(98)00106-7","article-title":"5-HT1A receptor function in normal subjects on clinical doses of fluoxetine: blunted temperature and hormone response to ipsapirone challenge","volume":"20","author":"Lerer","year":"1999","journal-title":"Neuropsychopharmacology"},{"key":"10.1016\/j.jpsychires.2008.09.001_bib25","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1038\/sj.npp.1300880","article-title":"Serotonin function in panic disorder. Important, but why?","volume":"21","author":"Maron","year":"2006","journal-title":"Neuropsychopharmacology"},{"key":"10.1016\/j.jpsychires.2008.09.001_bib26","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1080\/15622970410029927","article-title":"Association between serotonin-related genetic polymorphisms and CCK-4-induced panic attacks with or without 5-hydroxytryptophan pre-treatment in healthy volunteers","volume":"5","author":"Maron","year":"2004","journal-title":"World Journal of Biological Psychiatry"},{"key":"10.1016\/j.jpsychires.2008.09.001_bib27","doi-asserted-by":"crossref","first-page":"978","DOI":"10.1001\/archpsyc.63.9.978","article-title":"Differential effects of 5-HTTLPR genotypes on the behavioral and neural responses to tryptophan depletion in patients with major depression and controls","volume":"63","author":"Neumeister","year":"2006","journal-title":"Archives of General Psychiatry"},{"key":"10.1016\/j.jpsychires.2008.09.001_bib28","doi-asserted-by":"crossref","first-page":"751","DOI":"10.1007\/s00213-005-0034-3","article-title":"Long-term citalopram administration reduces responsiveness of HPA axis inpatients with major depression: relationship with S-citalopram concentrations in plasma and cerebrospinal fluid (CSF) and clinical response","volume":"181","author":"Nikisch","year":"2005","journal-title":"Psychopharmacology"},{"key":"10.1016\/j.jpsychires.2008.09.001_bib29","doi-asserted-by":"crossref","first-page":"300","DOI":"10.1097\/00004714-200206000-00011","article-title":"Antipanic drug modulation of 35% CO2 hyperreactivity and short-term treatment outcome","volume":"22","author":"Perna","year":"2002","journal-title":"Journal of Clinical Psychopharmacology"},{"key":"10.1016\/j.jpsychires.2008.09.001_bib30","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1002\/ajmg.b.30035","article-title":"Lack of relationship between CO2 reactivity and serotonin transporter gene regulatory region polymorphism in panic disorder","volume":"129B","author":"Perna","year":"2004","journal-title":"American Journal of Medical Genetics Part B (Neuropsychiatric Genetics)"},{"key":"10.1016\/j.jpsychires.2008.09.001_bib31","doi-asserted-by":"crossref","first-page":"2230","DOI":"10.1038\/sj.npp.1300822","article-title":"Antipanic efficacy of paroxetine and polymorphism within the promoter of the serotonin transporter gene","volume":"30","author":"Perna","year":"2005","journal-title":"Neuropsychopharmacology"},{"key":"10.1016\/j.jpsychires.2008.09.001_bib32","doi-asserted-by":"crossref","first-page":"539","DOI":"10.4088\/JCP.v57n1107","article-title":"Fluvoxamine attenuates panic induced by 35% CO2 challenge","volume":"57","author":"Pols","year":"1996","journal-title":"Journal of Clinical Psychiatry"},{"key":"10.1016\/j.jpsychires.2008.09.001_bib33","doi-asserted-by":"crossref","first-page":"519","DOI":"10.1016\/0197-0186(93)90025-Z","article-title":"Release of cholecystokinin in the central nervous system","volume":"22","author":"Raiteri","year":"1993","journal-title":"Neurochemistry International"},{"key":"10.1016\/j.jpsychires.2008.09.001_bib34","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/0005-7967(86)90143-9","article-title":"Anxiety sensitivity, anxiety frequency and the prediction of fearfulness","volume":"24","author":"Reiss","year":"1996","journal-title":"Behaviour Research and Therapy"},{"key":"10.1016\/j.jpsychires.2008.09.001_bib35","doi-asserted-by":"crossref","first-page":"559","DOI":"10.1016\/0028-3908(94)90087-6","article-title":"Effects of BOC-CCK-4 and L326,260 and cortical 5-HT release in guinea-pigs on exposure to the elevated plus maze","volume":"33","author":"Rex","year":"1994","journal-title":"Neuropharmacology"},{"key":"10.1016\/j.jpsychires.2008.09.001_bib36","doi-asserted-by":"crossref","first-page":"317","DOI":"10.1016\/0143-4179(95)90096-9","article-title":"Effects of acute systemic treatment with the 5 HT-uptake blocker alaproclate on tissue levels and release of substance P in rat periaqueductal grey","volume":"28","author":"Ros\u00e9n","year":"1995","journal-title":"Neuropeptides"},{"key":"10.1016\/j.jpsychires.2008.09.001_bib37","doi-asserted-by":"crossref","first-page":"308","DOI":"10.1037\/0021-843X.109.2.308","article-title":"Evaluating gene X psychological risk factor effects in the pathogenesis of anxiety: a new model approach","volume":"109","author":"Schmidt","year":"2000","journal-title":"Journal of Abnormal Psychology"},{"key":"10.1016\/j.jpsychires.2008.09.001_bib38","doi-asserted-by":"crossref","first-page":"553","DOI":"10.1177\/0269881104047283","article-title":"The effects of tianeptine or paroxetine on 35% CO2 provoked panic in panic disorder","volume":"18","author":"Schruers","year":"2004","journal-title":"Journal of Psychopharmacology"},{"key":"10.1016\/j.jpsychires.2008.09.001_bib39","first-page":"332","article-title":"Effects of citalopram on behavioural, cardiovascular and neuroendocrine response to cholecystokinin tetrapeptide challenge in patients with panic disorder","volume":"22","author":"Shlik","year":"1997","journal-title":"Journal of Psychiatry and Neuroscience"},{"key":"10.1016\/j.jpsychires.2008.09.001_bib40","doi-asserted-by":"crossref","first-page":"104","DOI":"10.1016\/S0006-8993(01)03158-4","article-title":"Effects of cholesystokinin tetrapeptide (CCK(4)) and anxiolytic drugs on the electrically evoked [(3)H]5-hydrocytryptamine outflow from rat cortical slices","volume":"922","author":"Siniscalchi","year":"2001","journal-title":"Brain Research"},{"key":"10.1016\/j.jpsychires.2008.09.001_bib41","doi-asserted-by":"crossref","first-page":"2226","DOI":"10.1038\/sj.npp.1300552","article-title":"Effects of serotonin transporter promoter polymorphisms on serotonin function","volume":"29","author":"Smith","year":"2004","journal-title":"Neuropsychopharmacology"},{"key":"10.1016\/j.jpsychires.2008.09.001_bib42","series-title":"Test manual for the state-trait anxiety inventory","author":"Spielberger","year":"1970"},{"key":"10.1016\/j.jpsychires.2008.09.001_bib43","doi-asserted-by":"crossref","first-page":"279","DOI":"10.1016\/S0028-3908(98)00176-2","article-title":"Anxiogenic effect of central CCK administration is attenuated by chronic fluoxetine or ipsapirone treatment","volume":"38","author":"To","year":"1999","journal-title":"Neuropharmacology"},{"key":"10.1016\/j.jpsychires.2008.09.001_bib44","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1007\/s00213-006-0351-1","article-title":"Tryptophan depletion does not modify response to CCK-4 challenge in patients with panic disorder after treatment with citalopram","volume":"186","author":"Toru","year":"2006","journal-title":"Psychopharmacology"},{"key":"10.1016\/j.jpsychires.2008.09.001_bib45","doi-asserted-by":"crossref","first-page":"357","DOI":"10.1007\/s002130050201","article-title":"Effect of the selective serotonin re-uptake inhibitor fluvoxamine on CCK-4 induced panic attacks","volume":"129","author":"Van Megen","year":"1997","journal-title":"Psychopharmacology"},{"key":"10.1016\/j.jpsychires.2008.09.001_bib46","doi-asserted-by":"crossref","first-page":"120","DOI":"10.1007\/s002130000432","article-title":"Serotonin transporter (5-HTT) promoter genotype may influence the prolactin response to clomipramine","volume":"150","author":"Whale","year":"2000","journal-title":"Psychopharmacology"},{"key":"10.1016\/j.jpsychires.2008.09.001_bib47","doi-asserted-by":"crossref","first-page":"371","DOI":"10.1001\/archpsyc.58.4.371","article-title":"Anxiolyticlike effects of atrial natriuretic peptide on cholecystokinin tetrapeptide-induced panic attacks: preliminary findings","volume":"58","author":"Wiedemann","year":"2001","journal-title":"Archives of General Psychiatry"},{"key":"10.1016\/j.jpsychires.2008.09.001_bib48","doi-asserted-by":"crossref","first-page":"979","DOI":"10.1038\/sj.npp.1300131","article-title":"Effects of alprazolam on cholecystokinin-tetrapeptide-induced panic and hypothalamic-pituitary-adrenal-axis activity: a placebo-controlled study","volume":"28","author":"Zwanzger","year":"2003","journal-title":"Neuropsychopharmacology"}],"container-title":["Journal of Psychiatric Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0022395608001854?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0022395608001854?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2019,5,14]],"date-time":"2019-05-14T19:47:09Z","timestamp":1557863229000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0022395608001854"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2009,3]]},"references-count":48,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2009,3]]}},"alternative-id":["S0022395608001854"],"URL":"https:\/\/doi.org\/10.1016\/j.jpsychires.2008.09.001","relation":{},"ISSN":["0022-3956"],"issn-type":[{"value":"0022-3956","type":"print"}],"subject":[],"published":{"date-parts":[[2009,3]]}}}